Search

everythinglearnresearchcommunity

for

Search:↓

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Tamoxifen caused hair loss in a 52-year-old woman.

Estrogen receptor α controls hair growth cycles and skin thickness in male mice.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Combined oral contraceptives and antiandrogens are effective for treating PCOS symptoms in older women.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Menopause can cause skin issues, and seeing a dermatologist helps.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Oral minoxidil may improve hair loss in men and women, but has some side effects.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.